[Report and Summary of Expert Meeting] The 3rd AMR Global Expert Meeting: Tokyo AMR One-Health Conference Side Event ~ Measures Necessary at Home and Abroad for Promotion of the Action Plan (November 14, 2017)
date : 4/12/2018
Tags: AMR
![[Report and Summary of Expert Meeting] The 3rd AMR Global Expert Meeting: Tokyo AMR One-Health Conference Side Event ~ Measures Necessary at Home and Abroad for Promotion of the Action Plan (November 14, 2017)](https://hgpi.org/en/wp-content/uploads/sites/2/3rd-AMR_JPNENG.png)
![](http://www.hgpi.org/photo/3rd AMR_TOP.jpg)
- Based on scientific evidence, Japan should consider the introduction of equipment for genetic diagnostic testing at an early date, as well as ways of promoting the utilization of genetic testing in clinical settings while also keeping in mind the limitations of insurance coverage.
- To prevent outbreaks at medical facilities, Japan should work to create an environment that makes early containment possible, including by offering public support for the storage of surveillance cultures, and by promoting diagnostic thoroughness in order to prevent mass outbreaks, and an environment that encourages early containment.
- To counteract infectious diseases at elderly care facilities or facilities where genetic diagnoses aren’t available, Japan should promote educational environments that can foster professionals such as microbiologists, or others with knowledge about public health.
- -Alongside push incentives (subsidies for drug development) for R&D at universities and pharmaceutical companies, it is important to implement pull incentives (incentives designed to reward drug development or provide returns on investment) that could help to increase the profit predictability for antibiotics for which low returns are expected and reflect the value of the drugs in their prices by considering how the drugs would be used under ideal situations where drugs are used appropriately.
- To enable the permanent monitoring of AMR, Japan must consider methods for highly reliable, cross-specialty data collection and utilization, as well as data analysis methods in the short-term.
- In order to comprehensively collect and utilize information about the kinds of resistant bacteria that commonly develop at elderly care facilities, Japan should consider working to promote the collection and utilization of data via regional networks.
- In order to facilitate correct understanding about infectious diseases among governments, medical facilities, and citizens, and in order to make it possible for Japan to consider, as a country, what safety measures should be implemented, Japan should create a culture of broadly sharing data on the usage of antibacterial drugs and other relevant issues.
- Japan should support the creation of scientific evidence that meets global standards for quality and reliability that has high, world-wide reliability and consider mechanisms for returning this evidence to clinical settings and to the public.
- Japan should promote cooperation between the technology sector and pharmaceutical companies. We should also support the sharing of data among governments, industry, and academia.
- Japan should display international leadership in combating AMR by investing funds in the promotion of basic research, both domestic and foreign, and in the maintenance and promotion of medical systems.
- In order to bolster the efforts of the One Health Approach, Japan should consider how to establish innovative mechanisms that would promote cooperation among industry, government, and academia, including in the agricultural and environmental fields.
- Along with ensuring access to antibacterial drugs in such a way that takes into account the actual circumstances of regional medical systems, Japan should go even further to exhaustively promote the proper use of antibacterial drugs in order to prevent the proliferation of resistant bacteria.
- Japan should recognize that AMR is a global concern and promote the further implementation of its National Action Plan, including from the perspective of the One Health Approach.
- Japan should work to communicate information about AMR around the world in the form of an action package that includes specific measures for achieving the goals specified in the action plan.
- While promoting the international development of advanced technologies to counteract infectious diseases, Japan should consider bilateral cooperation aimed at achieving universal health coverage (UHC) globally, as well as technological collaboration among specialists working in collaboration with the UN and other international agencies, and mechanisms that promote R&D.
- Japan should work independently as well to foster the international cooperation for the initiatives of the action plan.
- From the perspective of the One Health Approach, Japan should maintain an environment conducive to the sharing of initiatives across government organizations, academic research institutes, and industry related to AMR countermeasures, which are linked to a wide variety of issues such as the environment and food supplies.
- Not only governments, industry, and academia, but also the media and other stakeholders should take an active role in conveying correct information to the public.
- Kiyoshi Kurokawa (Chairman, Health and Global Policy Institute)
![](http://www.hgpi.org/photo/3rd AMR Kiyoshi Kurokawa.jpg)
- Chieko Ikeda (Senior Assistant Minister for Global Health, Ministry of Health, Labour and Welfare)
![](http://www.hgpi.org/photo/3rd AMR Chieko Ikeda.jpg)
- Chifumi Umeda (Executive Officer in charge of the Vaccine Business Unit and the Acute Diseases & Hospital Products Business Unit, MSD K.K.)
- Mitsuo Kaku (Professor, Infection Control and Laboratory Diagnostics, Internal Medicine, Department of Medical Sciences, Graduate School of Medicine, Tohoku University)
- Tomohiko Makino (Medical Officer, WHO West Pacific Regional Office)
- Michael Bell (Deputy Director, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention)
- Manami Takamatsu (Manager, Health and Global Policy Institute)
![](http://www.hgpi.org/photo/3rd AMR_Panel.jpg)
- Dame Sally Davies (Chief Medical Adviser to the UK Government/ Co-convener of the UN Inter-Agency Co-ordination Group on AMR.)
![](http://www.hgpi.org/photo/3rd AMR_Sally Davies.jpg)
- Yasuhisa Shiozaki (Member of the House of Representatives/ Former Minister of Health, Labour and Welfare)
![](http://www.hgpi.org/photo/3rd AMR Yasuhisa Shiozaki.jpg)
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)